Magnesium Citrate

Description

Leader Magnesium Citrate Lemon is a dietary supplement formulated to provide magnesium in the form of magnesium citrate. This compound is known for its high bioavailability and is often utilized to support various physiological functions, including muscle and nerve function. The product is presented in a lemon-flavored dosage form, enhancing palatability for users.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose to ensure proper administration.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum allowable dose of 10 fluid ounces within a 24-hour period.

For children aged 6 to under 12 years, the dosage is between 3 to 7 fluid ounces, with a maximum of 7 fluid ounces in a 24-hour period.

For children aged 2 to under 6 years, the recommended dosage is 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in a 24-hour period.

For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

The medication may be administered as a single daily dose or divided into multiple doses as deemed appropriate by the healthcare provider.

Contraindications

Use is contraindicated in patients with rectal bleeding or failure to have a bowel movement after use, as these may indicate a serious underlying condition.

Warnings and Precautions

Patients with a history of kidney disease should exercise caution when using this medication, as it may exacerbate their condition. Additionally, individuals on a magnesium-restricted diet must be aware of the potential for increased magnesium levels, which could lead to serious complications.

Abdominal pain, nausea, or vomiting may occur during treatment. If these symptoms arise, it is advisable to consult a healthcare professional. Furthermore, any sudden change in bowel habits that persists for more than two weeks warrants immediate medical evaluation, as it may indicate an underlying issue. Patients who have been using a laxative for longer than one week should also seek medical advice, as prolonged use can lead to dependency or other gastrointestinal complications.

In the event of an overdose, it is critical to seek emergency medical assistance or contact a Poison Control Center without delay.

Patients should discontinue use and contact their healthcare provider if they experience rectal bleeding or fail to have a bowel movement after administration. These symptoms may signify a serious medical condition that requires prompt attention.

Side Effects

Patients should be aware of several important warnings associated with the use of this medication. Individuals with kidney disease or those on a magnesium-restricted diet should exercise caution. Additionally, patients experiencing abdominal pain, nausea, or vomiting should consider discontinuing use and consulting a healthcare professional. A sudden change in bowel habits that persists for more than two weeks, or the use of a laxative for longer than one week, may also warrant medical attention.

Patients are advised to stop use and seek medical advice if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms could indicate a serious underlying condition.

Drug Interactions

The concomitant use of this product with other medications should be approached with caution. It is recommended that this product be administered at least 2 hours before or after other drugs. This precaution is necessary as the laxative properties of the product may influence the absorption and efficacy of concomitantly administered medications.

Healthcare professionals should monitor patients for any potential alterations in the therapeutic effects of other drugs when used in conjunction with this product. Adjustments to the dosing regimen of other medications may be warranted based on clinical response and the timing of administration.

Packaging & NDC

Below are the non-prescription pack sizes of Magnesium Citrate (leader magnesium citrate oral solution - lemon). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may receive a maximum dosage of 3 to 7 fluid ounces within a 24-hour period, with a strict limit of 7 fluid ounces. For children aged 2 to under 6 years, the recommended dosage is 2 to 3 fluid ounces in a 24-hour period, not exceeding 3 fluid ounces. For infants and children under 2 years of age, it is advised to consult a healthcare professional before administration.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a healthcare professional before using this medication. There is no specific data available regarding the excretion of this drug in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may require careful consideration regarding dosing adjustments and monitoring. In individuals with reduced kidney function, particularly those with kidney disease, it is essential to assess renal clearance to ensure appropriate therapeutic levels are maintained. Additionally, patients may need to adhere to a magnesium-restricted diet to prevent potential complications associated with elevated magnesium levels. Regular monitoring of renal function is recommended to guide treatment decisions and adjust dosages as necessary.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage in the provided sections of the Summary of Product Characteristics (SPL), healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdosage.

Recommended Actions In the event of an overdosage, it is essential for healthcare providers to assess the patient's clinical status and initiate appropriate supportive measures. Monitoring of vital signs and symptomatic treatment should be implemented as necessary.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should remain vigilant for any unusual or severe reactions that may arise following excessive administration of the product.

Management Procedures In the absence of detailed guidance, standard protocols for managing overdosage should be followed. This may include gastric decontamination, such as activated charcoal, if appropriate and within the timeframe of ingestion. Additionally, supportive care should be tailored to the individual patient's needs, focusing on stabilizing vital functions and addressing any emergent complications.

Healthcare professionals are encouraged to report any cases of overdosage to the relevant authorities to contribute to the ongoing assessment of the product's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to be aware of the signs that warrant discontinuation of the product; they should stop use and consult a doctor if they experience rectal bleeding or fail to have a bowel movement after use, as these symptoms may indicate a serious condition.

Patients should also be encouraged to consult with their healthcare provider or pharmacist prior to using this product if they are currently taking any other medications. It is essential to inform patients that this product should be taken at least 2 hours before or after the administration of other drugs, as laxatives may influence the efficacy of concurrent medications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its efficacy and safety. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Magnesium Citrate, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)